<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               <BR>                  7<BR>                    <BR>                  DRUG INTERACTIONS<BR>               <BR>               <BR>                  <BR>                     Tamoxifen<BR>                      <BR>                  <BR>                  Coadministration of Femara and tamoxifen 20 mg daily resulted in a reduction of letrozole plasma levels of 38% on average. Clinical experience in the second-line breast cancer trials indicates that the therapeutic effect of Femara therapy is not impaired if Femara is administered immediately after tamoxifen. <BR>                  <BR>                     Cimetidine<BR>                      <BR>                  <BR>                  A pharmacokinetic interaction study with cimetidine showed no clinically significant effect on letrozole pharmacokinetics. <BR>                  <BR>                     Warfarin<BR>                      <BR>                  <BR>                  An interaction study with warfarin showed no clinically significant effect of letrozole on warfarin pharmacokinetics.<BR>                  <BR>                     Other anticancer agents<BR>                  <BR>                  There is no clinical experience to date on the use of Femara in combination with other anticancer agents.<BR>               <BR>               <BR>            <BR>         </P></DIV></HTML>